CALLE DOCTOR FLEMING, 51 | 28036 MADRID, SPAIN
+34 91 3459395
info@oxonepi.com

CRO Services

As your Contract Research Organization, OXON helps plan and implement the generation of Real-World evidence for safety, market access/HEOR and drug development.

KNOW MORE

Late-phase studies 

We help pharmaceutical, biotech and  medical device companies to cost-effectively meet the requirements of late-phase clinical studies for better outcomes or greater value

KNOW MORE

Therapeutic Areas

OXON offers proven experience and a large portfolio of studies in all major therapy areas, including orphan conditions, pregnancy, and risk minimization.

KNOW MORE

Real World Evidence and Late-Phase Research

OXON has been selected as a preferred provider by several big pharma companies.
With strong links to EMA and world-renowned academics and institutions in Europe and Asia for studies and teaching, OXON offers proven experience and a large portfolio of studies in all major therapeutic areas

READ ABOUT US

OXON conducts:

• Primary data studies: prospective, registries, retrospective chart review, cross-sectional, surveys and pragmatic trials
• Secondary data studies: electronic records and registries
• Hybrid studies, including external controls for orphan medicines
• Synthesis research: systematic review and aggregate and IPD meta-analysis and landscaping
• Data analysis, modelling and simulation

World Class Science

Our specialization and high calibre allows us to have clear focus, deep expertise and superior insight to provide concrete results with maximum value to our clients.

Global Reach

We are specialised in multi-country observational studies and provide our real-world evidence services worldwide with the expertise and multi-language capabilities of our local partners. 

Strong Links

OXON’s services are reinforced with academic links with the London School of Hygiene & Tropical Medicine and with leading academic methodological and clinical consultants.

Long Term Alliances

OXON’s long-term alliance with a top tier global CRO provides us in-depth understanding of local requirements while keeping the flexibility needed to compete with the largest CROs.

We strive our best to support our clients in conducting cost-efficient observational studies worldwide

We pulled together 
professionals and resources to serve you better

READ MORE

Let us help design and conduct your optimal PASS or Outcomes observational study

OXON IS YOUR OBSERVATIONAL STUDIES SERVICE PROVIDER

OXON epidemiologists, statisticians, clinicians and project managers (ex-big pharma, ex-EMA), supported by consultancy from Stuart Pocock, Professor of Medical Statistics, London School of Hygiene & Tropical Medicine (´Pocock Stopping Rule´, sat on many data monitoring committees, extensive experience with EMA and FDA, classic textbook ´Clinical Trials´, 30+ NEJMs and 40+ Lancets)

REQUEST A MEETING

Newsroom

Read about us, our latest news and events 

MasterClassSeries-MasterSession4

RWE & Trials Live Masterclass Session 4: ‘Individualizing Benefit Risk’

RWE Masterclass 4: ‘Individualizing Benefit Risk’ Session 4: ‘Individualizing Benefit Risk’, will take place on Wednesday, 16 June 2021 at 5 pm CEST MORE INFORMATION|REGISTER HERE   SUMMARY: Conventional methods[…]

Read more
OXON Masterclass Series- Session3

RWE & Trials Live Masterclass Session 3: ‘Non-randomised Comparative Studies’

RWE Masterclass 3: ‘Non-randomised comparative studies’ Non-randomised comparative studies will be the main topic of the next session of our Real-World Evidence Masterclass Series. This Masterclass mini-series are meant for attendees[…]

Read more
Masterclass 2 Propensity Scores

RWE & Trials Live Masterclass Session 2: ‘The Tyranny of Propensity Scores’

RWE Live Masterclass 2: ‘The Tyranny of Propensity Scores’ Propensity Scores will be the main topic of the next session of our Real-World Evidence Masterclass Series. This Masterclass mini-series are[…]

Read more

Contact us! It will only take a minute

CONTACT US